Mashup Score: 1
VJHemOncJohn Gribben:Hello, I’m John Gribben. We’re at the iwCAR-T meeting in Tampa, Florida, and we’ve just come out of this CLL session, although we’re
Mashup Score: 1
VJHemOncJohn Gribben:Hello, I’m John Gribben. We’re at the iwCAR-T meeting in Tampa, Florida, and we’ve just come out of this CLL session, although we’re
#iwCART22 | Leading experts John Gribben, Mazyar Shadman, and Saar Gill discuss some of the barriers to CAR-T therapy in CLL & debate the optimal use of CAR-T in CLL: 🎥: https://t.co/LP6UyM1HQC #CLLsm #LeuSM #ImmunoOnc #HemOnc #CARTcell #tcellrx https://t.co/LP6UyM1HQC - view on twitter